Titlebook: Angiogenesis; From the Molecular t Michael E. Maragoudakis Book 2000 The Editor(s) (if applicable) and The Author(s), under exclusive licen

高調(diào)

dainty

0065-2598 the gapbetween basic and clinical methodology and understanding, presents themost up-to-date developments in this field.978-1-4613-6895-3978-1-4615-4221-6Series ISSN 0065-2598 Series E-ISSN 2214-8019

alabaster

,Der Verkaufsprozess im überblick,helial cells. FGF2 may therefore represent a target for antiangiogenic therapies. In order to assess the angiostatic potential of different classes of compounds, novel experimental models have been developed based on the autocrine and/or the paracrine capacity of FGF2.

Yag-Capsulotomy

DUCE

GROVE

Barter

Richard M. Denton,Jeremy M. Tavarétact inhibition. However, following long-term peripheral vasodilatation expansion of the capillary bed was accompanied by a co-ordinated increase in pericytes, such that coverage of capillaries was similar to that in control muscles. In addition, growth of capillaries following prolonged stretch res

FOR

斷言

Carl-Henrik Heldin,Bengt Westermark inhibition in CVEC prevented BK/B1 induced cell growth. These results substantiate the protective and trophic role of BK on microvascular endothelium by demonstrating that Bl receptor stimulation on venular endothelium is mandatory for the angiogenic effect of BK through its coupling to NOS activat

帶來(lái)墨水